Could the Inflammatory Prognostic Index Predict the Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer?
Could the Inflammatory Prognostic Index Predict the Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer? ASSISTANT PROFESSOR Atike Pınar ERDOĞAN Journal of Gastrointestinal Cancer click to read more